Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calem Kenward

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2023
Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2Hong Yu, Liam J Worrall, Thorsten Berger, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2023
Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2Hong Yu, Liam J Worrall, Thorsten Berger, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 2